METASTATIC BREAST CANCER: ENHERTU STOPS THE SPREAD

One in eight women will be diagnosed with breast cancer in their lifetime. Breast cancer is the second leading cause of cancer death for women, behind lung cancer, but after years of clinical trials, the FDA recently approved an exciting new targeted therapy for women with metastatic HER2-low cancer.